It was discovered that a high BOP1 level was related to poor PFI in BLCA, ACC, HNSC, KIRP, PAAD, UVM, KIRC, and PRAD, whereas a low BOP1 level was linked to poor PFI in GBM patients (Figures 5(f)–5(n)). The gene discussed is BOP1; the disease is prostate adenocarcinoma.